Humanwell Healthcare Group Co Ltd (600079) - Total Liabilities

Latest as of June 2025: CN¥16.15 Billion CNY ≈ $2.36 Billion USD

Based on the latest financial reports, Humanwell Healthcare Group Co Ltd (600079) has total liabilities worth CN¥16.15 Billion CNY (≈ $2.36 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Humanwell Healthcare Group Co Ltd - Total Liabilities Trend (2000–2024)

This chart illustrates how Humanwell Healthcare Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Humanwell Healthcare Group Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Humanwell Healthcare Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Humanwell Healthcare Group Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
MAZDA MOTOR UNSP.ADR/2
F:MZA0
Germany €2.27 Trillion
Gland Pharma Limited
NSE:GLAND
India Rs21.53 Billion
United Community Banks, Inc.
NYSE:UCB
USA $24.52 Billion
Veradermics, Incorporated
NYSE:MANE
USA $6.72 Million
Nordic Semiconductor ASA
OL:NOD
Norway Nkr328.31 Million
Titan Cement International SA
BR:TITC
Belgium €1.37 Billion
Shanghai Moons' Elec Co Ltd
SHG:603728
China CN¥1.45 Billion
Epoxy Base Electronic Material Corp Ltd
SHG:603002
China CN¥2.59 Billion

Liability Composition Analysis (2000–2024)

This chart breaks down Humanwell Healthcare Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Humanwell Healthcare Group Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.54 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.88 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.43 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Humanwell Healthcare Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Humanwell Healthcare Group Co Ltd (2000–2024)

The table below shows the annual total liabilities of Humanwell Healthcare Group Co Ltd from 2000 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥15.82 Billion
≈ $2.31 Billion
-1.80%
2023-12-31 CN¥16.11 Billion
≈ $2.36 Billion
-10.92%
2022-12-31 CN¥18.08 Billion
≈ $2.65 Billion
-4.09%
2021-12-31 CN¥18.85 Billion
≈ $2.76 Billion
+0.86%
2020-12-31 CN¥18.69 Billion
≈ $2.73 Billion
-11.07%
2019-12-31 CN¥21.02 Billion
≈ $3.08 Billion
-0.64%
2018-12-31 CN¥21.15 Billion
≈ $3.10 Billion
+12.51%
2017-12-31 CN¥18.80 Billion
≈ $2.75 Billion
+30.15%
2016-12-31 CN¥14.45 Billion
≈ $2.11 Billion
+61.04%
2015-12-31 CN¥8.97 Billion
≈ $1.31 Billion
+39.30%
2014-12-31 CN¥6.44 Billion
≈ $942.28 Million
+39.18%
2013-12-31 CN¥4.63 Billion
≈ $677.03 Million
+9.85%
2012-12-31 CN¥4.21 Billion
≈ $616.30 Million
+38.93%
2011-12-31 CN¥3.03 Billion
≈ $443.59 Million
+59.49%
2010-12-31 CN¥1.90 Billion
≈ $278.12 Million
+54.87%
2009-12-31 CN¥1.23 Billion
≈ $179.58 Million
-6.61%
2008-12-31 CN¥1.31 Billion
≈ $192.30 Million
+5.13%
2007-12-31 CN¥1.25 Billion
≈ $182.91 Million
+4.88%
2006-12-31 CN¥1.19 Billion
≈ $174.41 Million
-6.60%
2005-12-31 CN¥1.28 Billion
≈ $186.72 Million
+15.97%
2004-12-31 CN¥1.10 Billion
≈ $161.00 Million
+9.51%
2003-12-31 CN¥1.00 Billion
≈ $147.02 Million
+34.99%
2002-12-31 CN¥744.27 Million
≈ $108.91 Million
+25.15%
2001-12-31 CN¥594.72 Million
≈ $87.03 Million
+208.11%
2000-12-31 CN¥193.03 Million
≈ $28.25 Million
--

About Humanwell Healthcare Group Co Ltd

SHG:600079 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.92 Billion
CN¥26.78 Billion CNY
Market Cap Rank
#4249 Global
#701 in China
Share Price
CN¥16.41
Change (1 day)
-1.74%
52-Week Range
CN¥16.41 - CN¥23.03
All Time High
CN¥37.30
About

Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for pa… Read more